Abstract: The present invention relates to an isolated COP1 nucleic acid sequence from a maize plant and the isolated COP1 nucleic acid sequence is named as ZmCOP1. The present invention also relates to a method of using the ZmCOP1 nucleic acid sequence to control the shade avoidance response of a crop plant for high density farming and yield enhancement.

Abstract: A transient detection circuit which may be used in an electrostatic discharge (ESD) clamp circuit. The transient detection circuit includes a filter circuit and an inverter circuit. The voltage switch point of the inverter circuit has a constant voltage offset from one of the nodes. When a filtered voltage level from the filter circuit crosses the voltage switch point of the inverter circuit (indicative of an ESD event), the inverter circuit provides a signal indicating an ESD event.

Abstract: A patient alignment system for a radiation therapy system. The alignment system includes multiple external measurement devices which obtain position measurements of components of the radiation therapy system which are movable and/or are subject to flex or other positional variations. The alignment system employs the external measurements to provide corrective positioning feedback to more precisely register the patient and align them with a radiation beam. The alignment system can be provided as an integral part of a radiation therapy system or can be added as an upgrade to existing radiation therapy systems.

Abstract: Sedoheptulose 1,7-bisphosphatase (SBPase) is an enzyme catalyzing the reaction converting sedoheptulose 1,7-bisphosphate into sedoheptulose 7-phosphate. This enzyme is located in the chloroplast in leaves and stems. Overexpression of SBPase in transgenic plants is provided to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Deregulated variants of the enzymes are also provided.

Abstract: An optical flow is disclosed having a shell with a first portion and a second portion. The first portion provides a light entry aperture, and the second portion provides an imaging aperture. An inlet tube and an outlet tube are retained between the first portion and the second portion. A viewing assembly is retained between the first portion and the second portion. The viewing assembly includes a reference plate and a flow channel. The flow channel fluidly communicates with the inlet tube and the outlet tube. The reference plate extends from the shell to serve as a repeatable reference point for properly positioning the optical flow cell.

Abstract: A method and system for improving the working set of a program image. The working set (WS) improvement system of the present invention employs a two-phase technique for improving the working set. In the first phase, the WS improvement system inputs the program image and outputs a program image with the locality of its references improved. In the second phase, the WS improvement system inputs the program image with its locality of references improved and outputs a program image with the placement of its basic blocks in relation to page boundaries improved so that the working set is reduced.

Abstract: A cross-connect switch (1000) is adapted for a plurality of input channels in a synchronous network. Each input channel has a pointer processor (800) including a pointer interpreter (802), an elastic store buffer (804), and a pointer generator (806). The cross-connect switch (1000) further comprises a memory-less space switch (1020) interposed between a plurality of pointer interpreters (1010) and a plurality of elastic store buffers (1030). The space switch (1020) switches selected outputs of the plurality of pointer interpreters (1010) to inputs of each elastic store buffer (1000) in response to a switching control signal.

Abstract: A radiation treatment system (100) for accurately delivering radiation to a targeted site within a cancer patient (108) that includes a modular patient support system and a patient positioner (114). The modular patient support system includes a modularly expandable patient pod (200) and at least one immobilization device, such as, for example, a rigid moldable foam cradle (350). The patient pod (200) includes a generally hemi-cylindrical support shell (212) that extends longitudinally between proximal edge (214) and distal edge (216), and transversely between two lateral edges (222, 224). In one embodiment, the lateral edges (222, 224) are tapered to minimize edge effects that result when radiation beams traverse the lateral edges (222, 224).

Abstract: Disclosed is an apparatus and process for controlling space velocity in a fluidized catalytic conversion reactor. The catalyst flux rate can be adjusted during the process of the reaction to adjust the space velocity and maintain a fast fluidized flow regime therein. The set parameter in the reactor may be pressure drop which is proportional to catalyst density.

Abstract: The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the transcutaneous stimulation at a second location. The transcutaneous stimulation may be created by electric and/or magnetic fields. The first location may be relatively proximate to the cutaneous surface and may comprise tissue, nerves and muscle. Also, the second location may be relatively deeper than the first location and include, for example, brain tissue that requires the transcutaneous stimulation for treatment purposes. The invention further may include locating a conductor on a treatment area and/or a transcutaneous stimulation device relative to the first location. In addition, the method may further include adjusting how much the transcutaneous stimulation is reduced at the first location.

Abstract: A process for the preparation of a side-by-side or eccentric sheath-core bicomponent fiber wherein each component comprises a different poly(trimethylene terephthalate) composition.

Abstract: Provided are methods and compositions for the photodynamic therapy (PDT) of ocular conditions characterized by the presence of unwanted choroidal neovasculature, for example, neovascular age-related macular degeneration. The selectivity and sensitivity of the PDT method can be enhanced by combining the PDT with an anti-angiogenesis factor, for example, angiostatin or endostatin, or with an apoptosis-modulating factor. Furthermore, the selectivity and sensitivity of the PDT may be further enhanced by coupling a targeting moiety to the photosensitizer so as to target the photosensitizer to choroidal neovasculature.

Abstract: A system and a method is provided for fitting an aircraft cabin with modular sidewall panels, window reveals, and foam insulation blocks in an integrated manner. The system comprises a sidewall panel which may have one or more openings therethrough to receive a window reveal held by snap-fit fastenings. The bezel of the window reveal may be held by snap-fit fasteners for easy removal to allow removal and cleaning of the inner dust cover disassembly of the sidewall panel. Foam insulation blocks may be molded to fit in the cavity between the outer wall of the aircraft and the sidewall panels, held in place by compressive pressure between the frames of the airframe. The outer extent of the window reveal is tapered inwardly to guide the window reveal to mating contact with an outer window assembly in the aircraft fuselage without further adjustment of the sidewall panel.

Abstract: A transceiver including a controller, a first memory that includes first information, and a second memory accessible by a host is provided. The controller is configured to copy the first information from the first memory to the second memory.

Abstract: Compounds of the formula or a pharmaceutically acceptable salt or isomer thereof, wherein: Q, X and Z are CH or N; R, R4–R7 and R13 are H or alkyl; R1 is H, alkyl, fluoroalkyl, R9-arylalkyl, R9-heteroarylalkyl, alkyl-SO2—, cycloalkyl-SO2—, fluoroalkyl-SO2—, R9-aryl-SO2—, R9-heteroaryl-SO2—, N(R22)(R23)—SO2—, alkyl-C(O)—, cycloalkyl-C(O)—, fluoroalkyl-C(O)—, R9-aryl-C(O)—, NH-alkyl-C(O)— or R9-aryl-NH—C(O)—; R2 is H and R3 is H, alkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, R9-aryl, R9-arylalkyl, R9-heteroaryl, or R9-heteroarylalkyl, and when X and Z are each CH, R3 is alkoxy, R9-aryloxy, R9-heteroaryloxy, alkylC(O)O—, alkylaminoC(O)O—, alkylC(O)NR13—, alkylOC(O)NR13— or alkylaminoC(O)NR13—; or R2 and R3 together are ?O, ?NOR10, ?N—NR11R12 or ?CH-alkyl; R8 is substituted phenyl, substituted heteroaryl, naphthyl, fluorenyl, diphenymethyl, alpha-substituted benzyl or alpha-substituted heteroarylmethyl; R9–R12 are as defined; are disclosed for the treatment of HIV, solid organ transplant rejection, gra